June 30, 2020 / 6:24 AM / 12 days ago

BRIEF-AstraZeneca Says Selumetinib Granted Japan Orphan Drug Designation

June 30 (Reuters) - AstraZeneca PLC:

* ASTRAZENECA PLC - SELUMETINIB GRANTED JAPAN ORPHAN DRUG DESIGNATION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below